HSK7653 clinical trials
Also written HSK7653.
How each study uses HSK7653 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
Haisco Pharmaceutical Group Co., Ltd. (7) · Sichuan Haisco Pharmaceutical Group Co., Ltd (3)
Studies
Open first, then newest update. How each study uses HSK7653 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- HSK7653 in Chinese Patients with Impaired Glucose ToleranceCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT04727580Written as HSK7653 10mg Q2W
- A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes PatientsCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06703268Written as HSK7653 10 mg
- A Study to Evaluate the DDI of HSK7653 With MetforminCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT06084156Written as HSK7653
- Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DMCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06059326Written as HSK7653 10 mg
- Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy VolunteersCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT06003088Written as HSK7653(5mg)
- Single Escalating Dose Study Of HSK7653 In Healthy SubjectsCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT05983289Written as HSK7653
- A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal ImpairmentCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT05497297Written as HSK7653 tablets
- HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedPhase 3Sichuan Haisco Pharmaceutical Group Co., LtdNCT04564872Written as HSK7653 10 mg Q2W
- Mass Balance and Biotransformation of [14C]HSK7653 in HumanCompletedPhase 1Sichuan Haisco Pharmaceutical Group Co., LtdNCT04540016Written as [14C]HSK7653
- HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedPhase 3Sichuan Haisco Pharmaceutical Group Co., LtdNCT04556851Written as HSK7653 10 mg Q2W